Seniors
won't see their Medicare premiums reduced midyear after all - The
Washington Post
The Washington Post
And then in April, CMS finalized its plan to limit coverage
for the new drug to those enrolled in clinical trials, which greatly restricts
its use. ' ...
No comments:
Post a Comment